Figure 5.

Percent inhibition of pBaLEnv-recombinant HIV-1 by Ellagel. Ellagel was formulated with either 25 μM or 50 μM of ellagic acid (EA). Then, various concentrations of Ellagel were used in the experiments, shown on the x axes. The replication of recombinant virus was inhibited by Ellagel 50 μM EA (red points, panels A,C) and Ellagel 25 μM EA (green points, panels B,D) in a dose-dependent manner. Panels (C,D) show the same results as (A,B) but with a log₁₀ scale on the x axis. Dotted lines show the level of 50% inhibition of the virus (ID50). %Inhibition = [(replication without EA−replication with EA)/replication without EA] × 100.